[Pancreatic intraductal tubular carcinoma: a sub-group of intraductal papillary-mucinous tumors or a distinct entity? A case report and review of the literature].

PubWeight™: 0.84‹?›

🔗 View Article (PMID 17185972)

Published in Gastroenterol Clin Biol on November 01, 2006

Authors

Anne Thirot-Bidault1, Thierry Lazure, Raluca Ples, Stéphanie Dimet, Valérie Dhalluin-Venier, Monique Fabre, Gilles Pelletier

Author Affiliations

1: Service des Maladies du Foie et de l'Appareil digestif, Hôpital de Bicêtre, Le Kremlin-Bicêtre Cedex. anne.bidault@bct.aphp.fr

Articles by these authors

Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis (2002) 6.09

FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology (2007) 5.53

Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology (2006) 5.46

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci U S A (2006) 3.11

Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci U S A (2010) 2.91

[Clinical practice guidelines on the use of liver biopsy]. Gastroenterol Clin Biol (2002) 2.22

Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg (2012) 2.18

Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology (2004) 1.98

Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc (2010) 1.91

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Arthritis Res Ther (2006) 1.72

Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell (2008) 1.70

Hereditary persistence of alpha-fetoprotein is due to both proximal and distal hepatocyte nuclear factor-1 site mutations. Gastroenterology (2004) 1.65

Adams-Oliver syndrome and hepatoportal sclerosis: occasional association or common mechanism? Am J Med Genet A (2005) 1.61

Corynebacterium ulcerans in an immunocompromised patient with diphtheria and her dog. J Clin Microbiol (2005) 1.53

Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol (2003) 1.51

Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr (2002) 1.47

Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab (2004) 1.46

ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology (2010) 1.44

Complications of congenital portosystemic shunts in children: therapeutic options and outcomes. J Pediatr Gastroenterol Nutr (2010) 1.44

Widening spectrum of liver angiosarcoma in children. J Pediatr Gastroenterol Nutr (2011) 1.42

Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood (2005) 1.30

Hodgkin lymphoma-associated hemophagocytic syndrome: a disorder strongly correlated with Epstein-Barr virus. Clin Infect Dis (2008) 1.29

GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol (2011) 1.25

Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology (2003) 1.22

Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo. Hepatology (2002) 1.17

Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol (2003) 1.15

Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Hepatology (2004) 1.12

NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Sci Transl Med (2013) 1.12

Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy. Gastroenterology (2009) 1.11

Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice. Nat Biotechnol (2002) 1.11

Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour? Eur J Cancer (2011) 1.10

Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions. Gastrointest Endosc (2004) 1.09

Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literature. Virchows Arch (2005) 1.06

Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc (2002) 1.04

Metastatic tumors to the colon and rectum: a multi-institutional study. Arch Pathol Lab Med (2012) 1.02

Gastric inflammatory myofibroblastic tumors in children: an unpredictable course. J Pediatr Gastroenterol Nutr (2002) 1.02

Imatinib mesylate-induced acute hepatitis with autoimmune features. Eur J Gastroenterol Hepatol (2006) 1.01

CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway. Histopathology (2012) 1.00

Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol (2012) 0.99

Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2. J Hepatol (2012) 0.99

Induction of antigen-specific tolerance by intrathymic injection of lentiviral vectors. Blood (2006) 0.98

Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection. Cancer (2012) 0.97

WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries? Genes Chromosomes Cancer (2009) 0.96

Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C. World J Gastroenterol (2009) 0.95

IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report. J Pediatr Hematol Oncol (2008) 0.95

Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int (2005) 0.95

Perivascular epithelioid cell tumor: the first malignant case report in the pancreas. Appl Immunohistochem Mol Morphol (2013) 0.95

Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature. Hepatology (2014) 0.94

Peripancreatic paraganglioma: a potential diagnostic challenge in cytopathology and surgical pathology. Am J Surg Pathol (2011) 0.92

Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl (2005) 0.91

Fusarium keratitis and endophthalmitis associated with lens contact wear. Int Ophthalmol (2009) 0.91

Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Am J Surg Pathol (2012) 0.91

Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: Results of a pilot study. Gastrointest Endosc (2002) 0.91

Prenatal and postnatal Ciliated Hepatic Foregut Cysts in infants. J Pediatr Surg (2010) 0.90

Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody. Clin Gastroenterol Hepatol (2004) 0.90

Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome. Blood (2013) 0.90

Congenital anerythremic erythroleukemia presenting as hepatic failure. Arch Pathol Lab Med (2003) 0.89

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome. Hematol Oncol (2011) 0.89

Prognostic value of endoscopy in children with biliary atresia at risk for early development of varices and bleeding. Gastroenterology (2010) 0.89

ThinPrep-processed fine-needle samples of breast are effective material for RNA- and DNA-based molecular diagnosis: application to p53 mutation analysis. Cancer (2003) 0.88

EUS-guided FNA of pancreatic metastasis from renal cell carcinoma. Gastrointest Endosc (2003) 0.88

Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2. J Hepatol (2010) 0.87

Prognostic value of portal pressure at the time of Kasai operation in patients with biliary atresia. J Pediatr Gastroenterol Nutr (2006) 0.87

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21. Br J Haematol (2010) 0.87

Abnormal hepatic expression of fibrillin-1 in children with cholestasis. Am J Surg Pathol (2002) 0.87

The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms. Int J Cancer (2009) 0.86

Cholestasis in children with portal vein obstruction. J Pediatr (2005) 0.85

Giant cell hepatitis with autoimmune hemolytic anemia in early childhood: long-term outcome in 16 children. J Pediatr (2011) 0.85

Reliability, cost-effectiveness, and safety of reuse of ancillary devices for ERCP. Gastrointest Endosc (2004) 0.85

Double pancreatic and gastric adenocarcinomas: a rare association. Clin Res Hepatol Gastroenterol (2012) 0.85

Association of Adams-Oliver syndrome and hepatoportal sclerosis: an additional case. Am J Med Genet A (2006) 0.84

Endoscopic management of post-laparoscopic cholecystectomy biliary strictures. Long-term outcome in a multicenter study. Gastroenterol Clin Biol (2006) 0.84

Expression of erythropoietin and its receptor in neuroblastomas. Cancer (2007) 0.84

Immunohistochemical profile of ezrin and radixin in human liver epithelia during fetal development and pediatric cholestatic diseases. Clin Res Hepatol Gastroenterol (2013) 0.84

Pancreatic haemangioma in infancy: the place of radiology. Pediatr Radiol (2003) 0.82

Epstein-Barr virus infection and altered control of apoptotic pathways in posttransplant lymphoproliferative disorders. Pathobiology (2012) 0.82

High cyclin E staining index in blastemal, stromal or epithelial cells is correlated with tumor aggressiveness in patients with nephroblastoma. PLoS One (2008) 0.82

[Pancreatic vascular tumours of childhood: a heterogeneous nosologic spectrum]. Ann Pathol (2002) 0.82

[Angiomyofibroblastoma of the male genital tract. Pathological and immunohistochemical study of three cases]. Ann Pathol (2005) 0.82

Adjuvant interleukin-12 gene therapy for the management of colorectal liver metastases. Cancer Gene Ther (2004) 0.82

Separate occurrence of extra-adrenal paraganglioma and gastrointestinal stromal tumor in monozygotic twins: probable familial Carney syndrome. Pediatr Dev Pathol (2004) 0.81

Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain. J Biol Chem (2012) 0.81

French retrospective multicentric study of neonatal hemochromatosis: importance of autopsy and autoimmune maternal manifestations. Pediatr Dev Pathol (2012) 0.81

Histopathology of an iliac aneurysm in a case of Menkes disease. Pediatr Dev Pathol (2010) 0.81

Solid adenoma with exclusive hepatocellular differentiation: a new variant among pancreatic benign neoplasms? Virchows Arch (2002) 0.81

Erdheim-Chester disease in childhood: a challenging diagnosis and treatment. J Pediatr Hematol Oncol (2009) 0.81

[Phyllodes tumour of the prostate in a 28-year-old man]. Prog Urol (2007) 0.80

Reversibility of cirrhosis in HIV/HBV coinfection. Antivir Ther (2007) 0.80

Importance, mechanisms and limitations of the distant bystander effect in cancer gene therapy of experimental liver tumors. Cancer Lett (2002) 0.80

Integrated profiling of diffuse large B-cell lymphoma with 7q gain. Br J Haematol (2011) 0.79

[Osseous metaplasia in a colonic adenocarcinoma]. Gastroenterol Clin Biol (2003) 0.79

High level of apoptosis and low AKT activation in mass screening as opposed to standard neuroblastoma. Histopathology (2010) 0.79

Signet-ring cell change in acute erosive gastropathy. Am J Surg Pathol (2004) 0.79

Outcome of central hepatectomy for hepatoblastomas. J Pediatr Surg (2010) 0.79

Activation of the phosphatidylinositol 3'-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1. Hum Pathol (2011) 0.78

Renal cell carcinoma with an Xp11.2 translocation in a 16-year-old girl: a case report with cytological features. Diagn Cytopathol (2006) 0.78

Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features. Epigenetics (2015) 0.78

Hepatocellular carcinoma and occupation in men: a case-control study. J Occup Environ Med (2008) 0.78